Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from D.Western Therapeutics Institute ( (JP:4576) ).
D.Western Therapeutics Institute reported a decrease in net sales and operating profit for the nine months ending September 30, 2025, compared to the previous year. Despite the decline in financial performance, the company’s equity ratio improved significantly, indicating a stronger financial position.
The most recent analyst rating on (JP:4576) stock is a Hold with a Yen98.00 price target. To see the full list of analyst forecasts on D.Western Therapeutics Institute stock, see the JP:4576 Stock Forecast page.
More about D.Western Therapeutics Institute
D.Western Therapeutics Institute, Inc. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. The company focuses on developing therapeutic products, although specific products or market focus details are not provided in the release.
Average Trading Volume: 4,482,236
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen5.58B
Find detailed analytics on 4576 stock on TipRanks’ Stock Analysis page.